SecProbe.io - Filing

CORRESP Filing

bioAffinity Technologies, Inc.
Date: Sept. 26, 2025 · CIK: 0001712762 · Accession: 0001493152-25-015810

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-290480

Date

September 22, 2025

Author

Chief

Form

CORRESP

Company

bioAffinity Technologies, Inc.

Letter

bioAffinity Technologies, Inc.

Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(210) 698-5334

September 26, 2025

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Margaret Sawicki

Re: bioAffinity Technologies, Inc.

Registration Statement on Form S-1

Filed September 22, 2025

File No. 333-290480

Ladies and Gentlemen:

bioAffinity Technologies, Inc. (the "Company") hereby respectfully withdraws its request dated September 22, 2025 that the effective date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Time, on Tuesday, September 23, 2025, or as soon thereafter as possible.

Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 if there are any questions with respect to this request.

Very
truly yours,
BIOAFFINITY
TECHNOLOGIES, INC.

Show Raw Text

CORRESP
 1
 filename1.htm

 bioAffinity
Technologies, Inc.

 3300
Nacogdoches Road, Suite 216

 San
Antonio, Texas 78217

 (210)
698-5334

 September
26, 2025

 VIA
EDGAR

 United
States Securities and Exchange Commission

 100
F Street, N.E.

 Washington,
D.C. 20549

 Attention:
Margaret Sawicki

 Re:
 bioAffinity
 Technologies, Inc.

 Registration
 Statement on Form S-1

 Filed
 September 22, 2025

 File
 No. 333-290480

 Ladies
and Gentlemen:

 bioAffinity
Technologies, Inc. (the "Company") hereby respectfully withdraws its request dated September 22, 2025 that the effective
date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Time, on Tuesday,
September 23, 2025, or as soon thereafter as possible.

 Please
notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 if there are any questions
with respect to this request.

 Very
 truly yours,

 BIOAFFINITY
 TECHNOLOGIES, INC.

 By:
 /s/
 Maria Zannes

 Name:
 Maria
 Zannes

 Title:
 Chief
 Executive Officer